Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The gut-brain-astrocyte-axis in Alzheimer's disease
EF 2022-23
Résumé
Alzheimer’s Disease is the most common form of dementia, with an estimated 368,200 Canadians living with the disease in 2020. In the brain, it provokes the abnormal accumulation of proteins, which causes harm to surrounding neurons. Disease onset is also regulated by a specialized cell type in the brain known as astrocytes, which are crucial to the function of neurons. After injury, astrocytes can undergo modifications that allow them to either promote recovery or cause further damage. There are many types of these “reactive” astrocytes which researchers can identify by measuring changes in the way genes are used, or “expressed” in these cells. The mechanisms driving these alterations to astrocytes are not well understood, but recent research has demonstrated the involvement of small organisms that live along the digestive tract, known as gut microbiota. One way these organisms can influence the brain is through the release of bacterial by-products that travel to the brain, called metabolites. Of interest, the composition of the gut microbiome and its metabolites is altered in multiple neurological conditions, including Alzheimer’s Disease.
The aim of this project is to investigate the connection between the gut and the types of reactive astrocytes in Alzheimer’s Disease. We will do this using a mouse model of Alzheimer’s Disease with altered microbiome compositions. We will examine how these different microbiomes, and their metabolites, impact reactive astrocyte by analyzing the gene expression patterns of single cells.
This research will determine the importance of microbiota in the regulation of astrocytes in Alzheimer’s disease progression and further establish the gut as a target of future research and potential treatments for neurological disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486427
Name
gibbs rachel M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The gut-brain-astrocyte-axis in Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimers Disease; Astrocytes; Gut-Brain-Axis; Proteomics; Single Cell Sequencing
Abstract
Alzheimer’s Disease is the most common form of dementia, with an estimated 368,200 Canadians living with the disease in 2020. In the brain, it provokes the abnormal accumulation of proteins, which causes harm to surrounding neurons. Disease onset is also regulated by a specialized cell type in the brain known as astrocytes, which are crucial to the function of neurons. After injury, astrocytes can undergo modifications that allow them to either promote recovery or cause further damage. There are many types of these “reactive” astrocytes which researchers can identify by measuring changes in the way genes are used, or “expressed” in these cells. The mechanisms driving these alterations to astrocytes are not well understood, but recent research has demonstrated the involvement of small organisms that live along the digestive tract, known as gut microbiota. One way these organisms can influence the brain is through the release of bacterial by-products that travel to the brain, called metabolites. Of interest, the composition of the gut microbiome and its metabolites is altered in multiple neurological conditions, including Alzheimer’s Disease.
The aim of this project is to investigate the connection between the gut and the types of reactive astrocytes in Alzheimer’s Disease. We will do this using a mouse model of Alzheimer’s Disease with altered microbiome compositions. We will examine how these different microbiomes, and their metabolites, impact reactive astrocyte by analyzing the gene expression patterns of single cells.
This research will determine the importance of microbiota in the regulation of astrocytes in Alzheimer’s disease progression and further establish the gut as a target of future research and potential treatments for neurological disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
gibbs, rachel M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~